GoHealth (GOCO) to Release Earnings on Thursday

GoHealth (NASDAQ:GOCO) is anticipated to release its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect the company to announce earnings of ($2.69) per share and revenue of $88.62 million for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, March 12, 2026 at 12:30 PM ET.

GoHealth Stock Performance

NASDAQ:GOCO opened at $1.65 on Thursday. The firm has a market capitalization of $47.37 million, a PE ratio of -0.10 and a beta of 1.65. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 2.64. GoHealth has a 12-month low of $1.60 and a 12-month high of $21.00. The firm has a 50-day moving average price of $2.27 and a 200 day moving average price of $3.62.

Wall Street Analysts Forecast Growth

GOCO has been the subject of several analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of GoHealth in a research report on Monday, December 29th. William Blair reissued a “market perform” rating on shares of GoHealth in a report on Wednesday, November 19th. Finally, Royal Bank Of Canada reduced their target price on shares of GoHealth from $12.00 to $5.00 and set a “sector perform” rating on the stock in a research note on Wednesday, November 26th. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $5.00.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in GOCO. Bank of America Corp DE raised its holdings in GoHealth by 22.8% during the 4th quarter. Bank of America Corp DE now owns 7,831 shares of the company’s stock worth $105,000 after purchasing an additional 1,452 shares during the last quarter. Cubist Systematic Strategies LLC grew its position in shares of GoHealth by 297.3% during the 1st quarter. Cubist Systematic Strategies LLC now owns 10,915 shares of the company’s stock worth $134,000 after buying an additional 8,168 shares during the period. Empowered Funds LLC lifted its holdings in GoHealth by 7.7% in the first quarter. Empowered Funds LLC now owns 25,008 shares of the company’s stock valued at $307,000 after buying an additional 1,790 shares during the period. Jane Street Group LLC bought a new position in GoHealth in the first quarter valued at approximately $177,000. Finally, Geode Capital Management LLC grew its holdings in GoHealth by 4.3% during the 2nd quarter. Geode Capital Management LLC now owns 118,961 shares of the company’s stock worth $660,000 after acquiring an additional 4,955 shares during the period. Institutional investors and hedge funds own 24.21% of the company’s stock.

GoHealth Company Profile

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.